We report the cloning and characterization of a novel member of the Transcriptional Intermediary Factor 1 (TIF1) gene family, human TIF1g. Similar to TIF1a and TIF1b, the structure of TIF1b is characterized by multiple domains: RING ®nger, B boxes, Coiled coil, PHD/TTC, and bromodomain. Although structurally related to TIF1a and TIF1b, TIF1g presents several functional dierences. In contrast to TIF1a, but like TIF1b, TIF1g does not interact with nuclear receptors in yeast two-hybrid or GST pull-down assays and does not interfere with retinoic acid response in transfected mammalian cells. Whereas TIF1a and TIF1b were previously found to interact with the KRAB silencing domain of KOX1 and with the HP1a, MOD1 (HP1b) and MOD2 (HP1g) heterochromatinic proteins, suggesting that they may participate in a complex involved in heterochromatin-induced gene repression, TIF1g does not interact with either the KRAB domain of KOX1 or the HP1 proteins. Nevertheless, TIF1g, like TIF1a and TIF1b, exhibits a strong silencing activity when tethered to a promoter. Since deletion of a novel motif unique to the three TIF1 proteins, called TIF1 signature sequence (TSS), abrogates transcriptional repression by TIF1g, this motif likely participates in TIF1 dependent repression.
Introduction
Control of gene expression in higher eukaryotes is a complex process which provides many possibilities of regulation. A central role is played by sequence-speci®c transregulators which control positively or negatively the assembly and activity of the transcriptional machinery at promoter regions. Bridging (mediator) proteins may connect transregulators to components of the general transcriptional machinery or to proteins which are involved in chromatin structure remodeling to facilitate or restrict transcription.
Recently, progress has been made in the understanding of the dierential control of gene expression by nuclear receptors (NRs) which are ligand-dependent transregulators. Several interacting proteins have been isolated which may play an essential role in mediating their transcriptional activity (see Chambon, 1996; Horwitz et al., 1996; Glass et al., 1997 for review) . TIF1a, the ®rst member of the Transcriptional Intermediary Factor 1 (TIF1) family, was found to interact speci®cally and in a ligand-dependent manner with the ligand binding domain (LBD) of several NRs, including retinoid X (RXR), retinoic acid (RAR), vitamin D3 (VDR), estrogen (ER), and progesterone (PR) receptors, and it has been proposed to be a mediator of their transactivation function AF-2 (Le Douarin et al., 1995a; vom Baur et al., 1996) . In addition, TIF1a has been demonstrated to interact with the heterochromatinassociated factors HP1a, MOD1 (HP1b) and MOD2 (HP1g) . Moreover, an interaction was found with the so-called transcriptional silencing domain KRAB, which is present in about onethird of the vertebrate KruÈ ppel-type (C 2 H 2 ) zinc ®nger proteins (Moosmann et al., 1997) . TIF1a, like KRAB itself, can repress transcription in transient transfections when tethered to template DNA . Thus, TIF1a may play a dual role in the control of transcription, being involved in both repression and reactivation by agonist-bound NRs Losson, 1997) .
TIF1b, another member of the TIF1 gene family (also named KAP-1 and KRIP-1), was isolated by virtue of its interaction with HP1a and with the KRAB domain of the human KruÈ ppel-like protein KOX1 (Moosmann et al., 1996; Friedman et al., 1996; Kim et al., 1996) . TIF1b, like TIF1a, is a repressor when fused to a heterologous DNA binding domain (Moosmann et al., 1996; Friedman et al., 1996) . However, TIF1b is not an interacting partner for the ligand-dependent AF-2 of NRs to which TIF1a binds , suggesting that TIF1a and TIF1b are at least in part functionally distinct.
Based on amino acid homologies, a typical TIF1 domain structure has been ascribed to members of this family, comprising an N-terminal region which contains an RBCC (RING ®nger-B box-coiled coil) motif, a poorly conserved central region and a Cterminal region which contains a PHD/TTC ®nger and a bromodomain (Le Douarin et al., 1996, 1997).
Whereas RING ®ngers have been found in many proteins of diverse functions (Freemont, 1993; Saurin et al., 1996) , PHD/TTC ®ngers and bromodomains are characteristic motifs of proteins known to function at the chromatin level (Aasland et al., 1995; Koken et al, 1995; Haynes et al., 1992; Jeanmougin et al., 1997) . That TIF1a and TIF1b may control transcription by chromatin-related mechanism(s) is supported by their speci®c interactions with the heterochromatinic factors HP1a, b (MOD1) and g (MOD2) and by the recent ®nding that TIF1a is itself a chromatin-associated protein (E Remboutsika, R Losson and P Chambon, unpublished results), although direct eects on components of the general transcription machinery have also been postulated (Moosmann et al., 1997) .
In this paper, we report the cloning and functional analysis of a novel TIF1 family member, TIF1g, which is structurally closely related to TIF1a and TIF1b, but has very little functional features in common with TIF1a and TIF1b. TIF1g resembles the other TIF1s in that it can repress transcription in transiently transfected mammalian cells when tethered to promoter regions. However, in contrast to TIF1a and TIF1b, TIF1g does not interact with either the KRAB silencing domain of KOX1 or the heterochromatinic proteins HP1a, b and g. Moreover, TIF1g has no NR binding activity. Thus, although related to TIF1a and TIF1b, TIF1g may repress transcription through interactions with yet unidenti®ed molecular partners. We have identi®ed a new motif highly conserved between and unique to TIF1a, TIF1b and TIF1g, designated TSS (TIF1 signature sequence). Deletion of this motif results in abrogation of the transcriptional inhibitory activity of TIF1g, demonstrating that it participates in TIF1 dependent repression.
Results
Cloning and sequence analysis of the human TIF1a and TIF1g genes A cDNA library from HepG2 cells (human liver) was screened using the TIF1a portion of T18, the murine TIF1a/B-raf fusion cDNA (Miki et al., 1988) as a hybridization probe under low stringency conditions. Restriction mapping of positive clones yielded two dierent restriction patterns. The longest clones of both groups were sequenced and contained two fulllength cDNAs which were named hTIF1a and hTIF1g. While hTIF1a was the human homologue of mouse TIF1a (TheÂ nÄ ot et al., 1997), hTIF1g represented a novel member of the TIF1 family. The nucleic and amino acid sequences of both human TIF1a and TIF1g are shown in Figure 1 . Our sequence of hTIF1a diers from that reported by TheÂ nÄ ot et al. (1997) (Genbank Accession No. AF 009353), especially in the GC-rich 5' portion. As a consequence, apart from isolated amino acid changes, residues 14 ± 25 (RLGCAPGGPRGG) are replaced by AASAAASGGPSAAPS, which is also more closely related to the corresponding murine sequence. As previously reported (TheÂ nÄ ot et al., 1997), the predicted mouse and human TIF1a protein sequences are identical at more than 92% of the residues. Amino acid comparison of the human TIF1g sequence to the sequences of human TIF1a and TIF1b revealed 48% overall identity with respect to TIF1a and 32% with respect to TIF1b (Figure 2a ). Among the three members of the family, TIF1a is closer to TIF1g than to TIF1b (28% overall identity between human TIF1a and human TIF1b).
Like TIF1a and TIF1b, TIF1g contains several evolutionary conserved domains (Figures 1b and 2a) . Near the N-terminus a C 3 HC 4 zinc ®nger motif or RING ®nger is followed in sequence by two B boxtype ®ngers and a predicted a-helical coiled coil domain forming a tripartite motif, designated RBCC (Saurin et al., 1996) . Towards the C-terminus a bromodomain (Haynes et al., 1992; Jeanmougin et al., 1997 ) is preceded by a C 4 HC 3 zinc ®nger motif or PHD/TTC ®nger (Aasland et al., 1995; Koken et al., 1995) . In addition to these conserved domains found in a number of transcriptional regulatory proteins (see Discussion), we identi®ed a 25 amino acid-long, tryptophan-and phenylalanine-rich sequence located downstream of the coiled coil motif (underlined in Figure 1a and b) which is highly conserved between the three TIF1 proteins and virtually identical between TIF1a and TIF1g ( Figure 2b ). As protein sequence searches using this region of homology did not reveal any signi®cant similarity to known proteins, we designated it TSS for TIF1 signature sequence. The central region between the TSS motif and the PHD/ TTC ®nger, extending over *370, 220, and 410 residues in TIF1a, TIF1b and TIF1g, respectively, is the least conserved among TIF1 proteins (Figure 2a) . Interestingly, two adjacent subfragments of the TIF1a central region have been shown to mediate protein interactions : the HP1 box to which HP1a, MOD1 (HP1b) and MOD2 (HP1g) bind (amino acids 675 ± 701; underlined in Figure 1a ) and the NR box in which integrity of the conserved motif LxxLL is essential for receptor interactions (amino acids 725 ± 734; underlined in Figure 1a ). While there is no motif clearly resembling the HP1 box of TIF1a in the TIF1g sequence, an LxxLL motif has been identi®ed in the central region (amino acids 696 ± 700; underlined in Figure 1b ), which however did not display any direct interaction with NRs.
Chromosomal localization of human TIF1a and TIF1g
Since TIF1a and two other RBCC proteins, RFP and PML, have been implicated in oncogenic translocations (Freemont, 1993; Saurin et al., 1996) , we determined the chromosomal localization of the TIF1a and TIF1g genes. In situ hybridizations were performed with 3 Hlabeled hTIF1a and hTIF1g cDNA probes on chromosome preparations from PHA-stimulated human lymphocytes. As shown in Figure 3 , non-random distributions of silver grains were obtained, allowing to map hTIF1a to the q32 ± q34 region of the long arm of chromosome 7, and hTIF1g to the p13 band of the short arm of chromosome 1. For the TIF1g probe, a small secondary peak was detected on the 1p34.3 ± 1p36.1 region of the short arm of chromosome 1, which leads us to speculate about the existence of another, yet unknown member of the TIF1 family. Since this probe failed to label the TIF1a and the TIF1b genes, this hypothetical fourth member is likely closer to TIF1g. Note that the hTIF1b gene is positioned to the q13.4 region of the long arm of chromosome 19 (Moosmann et al., 1996) . The locus 1p13, which contains the TIF1g gene, is strongly associated with the non-random t(1;22)(p13;q13) chromosomal translocation of acute megakaryocytic leukemias, whereas the involvement of 7q32 ± q34 in deletions and translocations of acute lymphoblastic leukemias, and that of 1p34 ± p36 in acute leukemias and myelodysplastic syndromes appears weaker (Mitelman, 1993) .
Tissue distribution and expression of human TIF1a and TIF1g transcripts
Northern blot analysis was used to characterize TIF1a and TIF1g expression in a variety of human adult tissues. While TIF1a, like TIF1b (Kim et al., 1996) , was expressed as a single transcript in all tissues examined, TIF1g exhibited a complex expression pattern with at least ®ve dierent transcripts ranging from 2.5 ± 8.8 kg (Figure 4 ). Some tissues (e.g. brain, lung, liver, kidney) expressed a single species, whereas others (e.g. testis, heart, skeletal muscle) contained several species. Moreover, the amount of TIF1g transcripts appeared to greatly vary among dierent tissues (Figure 4) .
Transcriptional repression by TIF1g in transfected mammalian cells
We investigated whether TIF1g, like TIF1a and TIF1b, exerts a silencing activity when recruited to promoter regions. The coding sequence of TIF1g was fused to the DBD or GAL4, amino acids 1 ± 147, and the resulting fusion protein was tested for its ability to repress transactivation by the chimeric activator ER(C) ± VP16 containing the DBD of ER fused to the acidic activation domain (AAD) of the herpes simplex virus VP16 activator (amino acids 411 ± 490). Expression vectors for GAL4 ± TIF1g and ER(C) ± VP16 were transiently transfected into COS-1 cells, together with a GAL4 reporter containing two GAL4 Figure 1 Nucleic and amino acid sequences of hTIF1a (a) and hTIF1g (b). Sequence positions are indicated on the left; characteristic domains and motifs are outlined and named on the right. The putative nuclear localization signals (KRK/KKK or KK/KKK, respectively) and an LxxLL motif in hTIF1g, as well as stop codons, are underlined binding sites (17M2) and an estrogen response element (ERE) in front of a b-globin (G) promoter-CAT fusion (17M2-ERE-G-CAT). For comparison, assays were also performed with GAL4 ± TIF1a. As shown in Figure 5a , GAL4 ± TIF1a as well as GAL4 ± TIF1g led to a strong repression of the reporter compared to GAL4 alone. In contrast, no reduction in CAT activity was detected by coexpressed TIF1g unfused to the GAL4 DBD, indicating that repression by TIF1g is dependent on DNA binding. Thus, similarly to TIF1a and TIF1b, TIF1g has a potent transrepression activity.
The TSS motif is responsible for transcriptional repression by TIF1g
To determine whether the highly conserved and speci®c TIF1 signature sequence could mediate a common function of the TIF1 proteins, such as transcriptional repression, we deleted the C-terminal two-thirds of the TSS in the GAL4-TIF1g fusion vector. As shown in Figure 5 , transcriptional repression was abrogated (rather, an activation was found) in transient cotransfection assays with COS-6 cells, implying that the TSS is crucial for the transcriptional inhibitory activity of TIF1g.
Modulation of nuclear receptor function by human TIF1a and TIF1g
To investigate whether human TIF1a and TIF1g could modulate nuclear receptor function, we performed transient cotransfection assays with thymidine-kinase promoter driven luciferase reporter genes under the control of multimeric DR5 retinoic acid response elements (de TheÂ et al., 1990) in CHO cells. Expression of human TIF1a inhibited the level of retinoic acid-dependent transcription in a dosedependent manner (Figure 6 ). Conversely, similar expression of TIF1g did not signi®cantly aect the reporter gene activity (Figure 6 ). The activation detected with TIF1g was not signi®cant because a comparable activation was found with both TIF1a and TIF1g on a tk-luc reporter construct without response elements (data not shown). Thus, in contrast to TIF1a , TIF1g does not interfere with retinoic acid response in transfected mammalian cells.
TIF1g has no NR binding activity
The yeast two hybrid system was used to investigate whether TIF1g could exhibit some NR binding activity, although, contrarily to TIF1a, it was unable to interfere with ligand-dependent transactivation in vivo (Figure 6 ). Full-length TIF1g was fused to the DBD of ER and the resulting hybrid protein (DBDTIF1g; Figure 7b ) was co-expressed in the yeast reporter strain PL3, which contains an URA3 reporter gene controlled by three EREs (Figure 7a ; Le Douarin et al., 1995b), with either`unfused' AAD (as control) or AAD fusions consisting of the AAD of VP16 fused to various members of the NR family (AAD ± RAR, AAD ± RXR, AAD ± TR(DE) and AAD ± ER(DEF); Figure 7b ). In addition, residues (b) Abrogation of transcriptional repression by partial deletion of the TSS motif in GAL4 ± TIF1g. COS-6 cells were transiently cotransfected with 1 mg of 17M2-ERE-G-Luc reporter, 1 mg of ptk-bgal (Stratagene), 100 ng of ER(C)-VP16, and 3 mg of GAL4 ± TIF1g or GAL4 ± TIF1g(D466 ± 479), respectively. CAT or luciferase activities are expressed relative to the activity measured in the presence of ER(C) ± VP16 alone (taken as 100%). Values (+10%) represent the averages of two resp. three independent duplicated transfections after normalization for b-galactosidase Figure 6 Modulation of retinoic acid-dependent transcription by hTIF1a and hTIF1g. CHO cells were transiently transfected with 0 ± 5 mg of either hTIF1a ± pSG5, hTIF1g ± pSG5 or empty pSG5 expression vector, 1 mg of RARE-tkLuc reporter plasmid and 1 mg of pCH110. After 24 h of retinoic acid (1 mM) treatment, luciferase activity of cell extracts was measured in a luminometer. Values (+10%) represent the averages of three independent transfections and are expressed as per cent of those obtained using the reporter vector alone (taken as 100%) after normalization for b-galactosidase 694 ± 702 of TIF1g which contain an LxxLL motif related to the NR box of TIF1a (Figure 1b ; Le were fused to the ER DBD and tested for NR interaction (Figure 7b) . Activation of the reporter was determined by measuring the speci®c activity of the URA3 gene product, orotidine 5'-monophosphate decarboxylase (OMPdecase; Figure  7b ). No signi®cant increase in OMPdecase activity above the AAD control was detected when DBD ± TIF1g or DBD ± TIF1g(694 ± 702) was co-expressed with AAD ± NRs in either the presence or absence of the appropriate NR ligand, whereas under the same conditions, co-expression of DBD ± TIF1a with any of the AAD ± NR fusions tested resulted in a liganddependent stimulation of the reporter gene activity (Figure 7b ). Note that the relative expression levels of the DBD ± TIF1a and ± TIF1g fusion proteins were similar (see legend to Figure 7b) . Thus, TIF1g, in contrast to TIF1a, is unable to interact with RAR, RXR, TR, and ER in yeast. Binding assays between TIF1g and NRs were also performed in vitro. In agreement with the yeast results, no signi®cant interaction was detected between in vitro-translated
TIF1g and GST ± RAR(DEF), GST ± RXR(DE), GST ± ER(DEF) or GST ± TR(DE) fusion proteins, irrespective of the presence of ligand (data not shown).
TIF1g interacts neither with the heterochromatinic proteins HP1a, b and g nor with the KRAB repression domain of KOX1 TIF1a and TIF1b have been shown to interact with the heterochromatinic proteins HP1a, b and g as well as with the transcriptional repression domain KRAB of KOX1. Using the yeast two hybrid system, TIF1g fused to the AAD of VP16 (AAD ± TIF1g; Figure 7c ) was tested for activation with either DBD ± HP1a, DBD ± MOD1/HP1b, DBD ± MOD2/HP1g, or DBD ± KRAB in the yeast reporter strain PL3. No increase in OMPdecase activity above the DBD control was observed, whereas in all combinations tested, the presence of AAD ± TIF1a or AAD ± TIF1b did stimulate expression of the URA3 reporter gene (Figure 7c) . Thus, TIF1g, in contrast to TIF1a and TIF1b, has no HP1 binding activity and is not a target for the highly conserved KRAB repression domain. Figure 7d shows the dimerization capacities of the TIF1 proteins as tested in yeast two hybrid screens: both AAD ± TIF1b and AAD ± TIF1g increased OMPdecase activity when coexpressed with DBD ± Figure 7 TIF1g does not interact with any of the known TIF1a-and TIF1b-partners. (a) Schematic representation of the yeast two hybrid system used in this study. The DNA binding domain (DBD) of the estrogen receptor (ERa; amino acids 176 ± 282) and the acidic activation domain (AAD) of VP16 (amino acids 411 ± 490) unfused or fused to the proteins tested for interaction (white boxes) are shown. The URA3 reporter gene which is regulated by three estrogen response elements (ERE3X) in the yeast reporter strain PL3 is represented below. (b) TIF1g, in contrast to TIF1a, has no nuclear receptor binding activity in yeast. Plasmids expressing mTIF1a, hTIF1g or residues 694 ± 702 of hTIF1g fused to the ERa DBD were introduced into PL3 together with VP16 AAD (as a control) or AAD fusions as indicated. Transformants were grown in the presence (+) or absence (7) of the cognate ligand (500 nM ATRA for RARa, 500 nM 9cis-RA for RXRa, 5 mM T3 for TRa, 500 nM E2 for ERa). Extracts were prepared and assayed for OMPdecase activity (in nmol substrate/min/mg protein). (c) TIF1g in contrast to TIF1a and TIF1b does not interact with HP1a, MOD1 (HP1b), MOD2 (HP1g) or the KRAB domain of KOX1 in yeast. Plasmids expressing mTIF1a, mTIF1b, or hTIF1g fused to the AAD of VP16 were co-expressed in the yeast reporter strain PL3 with either AAD or the indicated AAD fusions containing the coding sequences of the mouse HP1a, MOD1 (HP1b), MOD2 (HP1g) or the KRAB repression domain of the human KOX1 (residues 1 ± 97). OMPdecase activities determined on each cell-free extract are expressed as in (a). Note that in all cases expression of DBD and AAD fusion proteins was con®rmed by Western blotting using the antibodies F3 against the F region tag of the ERa DBD and 2GV-4 against VP16, respectively (4). In (a) and (b), the values (+20%) are the averages of three independent experiments. (d) Homo-and heterodimerization of the TIF1 proteins in yeast two hybrid assays TIF1a or DBD ± TIF1g. Compared to TIFIb, AAD ± TIF1g and DBD ± TIF1g fusion proteins had a much weaker expression, as demonstrated by Western blot analysis (data not shown), but nevertheless sucient to detect a heterodimerization among all three TIF1 proteins as well as homodimerization of TIF1g.
Evidence for homo-and heterodimerization of TIF1 proteins

Discussion
TIF1g is the third member of the TIF1 gene family to be identi®ed. In situ chromosomal hybridization suggests the existence of a fourth TIF1 gene. Extensive cDNA library screening failed to isolate this fourth gene which could be a pseudogene or could have a very restricted expression pattern. Like TIF1a and TIF1b, TIF1g possesses an N-terminal RING ®nger adjacent to two B boxes (Reddy et al., 1992) . These domains together with a putative coiled coil domain form a conserved motif (known as RBCC; Le Douarin et al., 1995a; Saurin et al., 1996) , the function of which is still unknown. Interestingly, TIF1a along with other RBCC family members such as RFP, XNF7, PwA33 and PML have been found in close association with speci®c subnuclear structures. TIF1a is a non-histone chromosomal protein (E Remboutsika, R Losson and P Chambon, unpublished results); RFP in a nuclear matrix-associated protein (Takahashi et al., 1988) ; XNF7 associates with the spindle in mitotic cells and with the centrosomes during interphase, dependent upon the presence of an intact B-box domain (Li et al., 1994) ; wild type PwA33, but not PwA33 mutated in the B-box, is present in the lampbrush chromosome loops of Pleurodeles oocytes (Bellini et al., 1995) ; PML is normally localized on large matrix-associated nuclear domains (Daniel et al., 1993; Dyck et al., 1994; Koken et al., 1994; Weiss et al., 1994) comprising several proteins; their formation is prevented by point mutations in the RING ®nger, the B-box domains, or the coiled coil region (Boddy et al., 1997) . Thus, the RBCC motif may be involved in intermolecular interactions which in¯uence the targeting to (and/or assembly of) subnuclear structures. Remarkably, three of the presently known RBCC proteins, i.e. TIF1a, PML and RFP, were found in the context of fusion oncoproteins, in which the RBCC motif is fused to truncated products of other genes (B-raf, RARa, and ret respectively), suggesting that the RBCC motif may play a crucial role in cell transformation. Towards its C-terminus, TIF1g contains two other domains of unknown function, the PHD/TTC ®nger and the bromodomain, which are also present in the Cterminal moiety of TIF1a and TIF1b. These domains, which are conserved from yeast to humans, have been identi®ed in a number of transcriptional mediators/ coactivators, several of which function at the chromatin level (Aasland et al., 1995; Koken et al., 1995; Jeanmougin et al., 1997) . For instance, the Drosophila gene products Trithorax and Polycomblike, which are both chromatin-associated proteins, contain multiple PHD/TTC ®ngers (Aasland et al., 1995; Koken et al., 1995) . The CBP/p300 histone acetyltransferase, which has been demonstrated to interact functionally with a number of sequencespeci®c transcriptional activators such as nuclear receptors, also contains a bromodomain and a PHD/ TTC ®nger (see Shikama et al., 1997 for review) . Thus, in view of their amino acid sequence, members of the TIF1 gene family may be implicated in chromatinmediated transcriptional regulation. Finally, the LYSP100 gene product, which in part colocalizes with SP100 and PML in discrete nuclear domains, also harbors a PHD/TTC and bromodomain (Dent et al., 1996) . In addition to a similar domain organization, the TIF1 gene products share a 25 amino acid long sequence located in the N-terminal part of their poorly conserved central region. This conserved sequence was designated TSS for TIF1 signature sequence as it was unique to members of the TIF1 family. By deletional mutagenesis, we have shown that this TSS motif is responsible for transcriptional repression by TIF1g. The high degree of conservation of the TSS between all three TIF1 family members suggests an identical function of this motif in TIF1a and TIF1b, too.
The majority of acute promyelocytic leukemias (APL) results from the t(15;17) translocation which combines the RBCC motif of PML and the CDEF region of RARa (see Warrell et al., 1993; Grignani et al., 1994; Grimwade and Solomon, 1997; Quignon et al., 1997 for review) . Recently, the recurrent translocation t(8;16)(p11;p13), which is associated with a subtype of acute myeloid leukemias (AML), has been demonstrated to recombine two distinct PHD ®nger proteins, CBP/p300 and MOZ, which are both acetyltransferases (Borrow et al., 1996) . Also, reciprocal translocations involving the human homolog of Drosophila Trithorax, ALL-1, are frequently associated with acute leukemias (Gu et al., 1992) . The TIF1g gene has been mapped to the 1p13 locus. Interestingly, a non-random t(1;22)(p13;q13) chromosomal translocation involving this region has been reported in acute megakaryocytic leukemias (Mitelman, 1993) . We are currently investigating the possible implication of TIFg in rearrangements of human acute leukemias.
Using a GAL4-TIF1g fusion protein, we found that TIF1g, similar to TIF1a and TIF1b, can exert a silencing eect in transfected cells when recruited to the promoter region of a reporter gene Moosmann et al., 1996; Friedman et al., 1996) . However, we have been unable to detect any association between TIF1g and the heterochromatinic proteins HP1a, HP1b (MOD1), and HP1g (MOD2), which have been demonstrated to interact directly with TIF1a and TIF1b ; and this study). Also, no interaction has been detected between TIF1g and the KRAB silencing domain of KOX1 to which TIF1a and TIF1b bind speci®cally (Moosmann et al., 1996; Le Douarin et al., 1997) . Thus, although related to TIF1a and TIF1b, TIF1g may repress transcription through interactions with yet unidenti®ed molecular partners.
Materials and methods
Plasmids
Receptor cDNAs used correspond to human RARa1 and ERa, mouse RXRa, and chicken TRa (EMBL data bank). DBD and AAD fusion proteins were expressed from the yeast multicopy plasmids pBL1 and pASV3 respectively (Le Douarin et al., 1995b) . pBL1 contains the HIS3 marker and directs the synthesis of epitope (human ERa F region)-tagged ERa DBD fusion proteins. pASV3 contains the LEU2 marker and a cassette expressing a nuclear localized VP16 acidic activation domain (AAD), preceding a polylinker, and stop codons in all reading frames. All inserts cloned into pBL1 and pASV3 were veri®ed by sequencing. For transfection studies in mammalian cells, the indicated cDNAs were cloned into pSG5 (Green and Chambon, 1988) , GAL4(1 ± 147) chimeras were constructed into pG4MpolyII (Tora et al., 1989) .
The deletion mutant GAL4 ± TIF1g(D466 ± 479), which replaces the C-terminal amino acids of the TIF1g ± TSS (WAKNVVNLGNLVIE) by a single glycine residue, was constructed by use of the two P¯MI sites at nucleotides 1473 and 1529, and a spacer (containing a unique BamHI site) derived from annealing of oligonucleotides CGGATC-CAAACCAGCTC (coding) with CTGGTTTGGATCC-GAAG (non-coding).
The chimeric protein ER(C) ± VP16, which encodes amino acids 176 ± 280 of ERa and amino acids 413 ± 490 of VP16, has been described previously (Tora et al., 1989) as well as the reporter genes 17M2-ERE-G-CAT (Tora et al., 1989) and RARE-tkLuc (de TheÂ et al., 1990) . The 17M2-ERE-G-Luc was derived from 17M2-ERE-G-CAT by substitution of the CAT box by the full-length luciferase gene (De Wet et al., 1987) .
cDNA cloning and sequence analysis
A HepG2 (human liver) cDNA library was hybridized under low stringency conditions with a radiolabeled probe comprising the TIF1a portion of T18, the murine TIF1a/Braf fusion cDNA, a gift from Miki and Aaronson (Miki et al., 1988) . Library screening, phage growth, DNA isolation, restriction mapping, and subcloning into the Bluescript II SK+ phagemid (Stratagene) or pSG5 plasmid were performed by standard procedures (Sambrook et al., 1989) . Both strands of the reported DNA sequences were determined from double-stranded and single-stranded (`shotgun' M13mp18) templates by the Sanger technique using T7 polymerase kits (Pharmacia). The highly CG-rich 5' part of hTIF1g was additionally sequenced by the MaxamGilbert method. DNA sequences were analysed with the aid of the Bisance software of the University of Paris; protein alignments were done with the FastA program.
In-situ hybridization for gene mapping Chromosome spreads were prepared from phytohemagglutinin-stimulated human lymphocytes cultured for 65 h, plus 7 h with 5-bromodeoxyuridine (60 mg/ml) for chromosomal banding quality. Full-length cDNAs of hTIF1a and hTIF1g were tritium labeled by nick-translation and hybridized to metaphase spreads as previously described (Mattei et al., 1985) . Slides were coated with nuclear track emulsion (Kodak NTB 2 ), autoradiographed for 20 days at 48C, Giemsa stained, and metaphases were photographed. R-banding was performed by the¯uorochrome-photolysis-giemsa (FPG) method. At least 100 metaphases were evaluated for gene mapping.
Northern blot analysis
Multiple-human-tissue Northern blots (Clontech Laboratories Inc.) were hybridized with the full-length cDNA of either human TIF1a, human TIF1g, or human b-actin (control), labeled with a-32 P-dCTP by random priming, according to the manufacturer's instructions.
Transient transfection
Transient transfections of mammalian cells were performed by the calcium phosphate method (Sambrook et al., 1989) . Assays for chloramphenicol acetyltransferase and luciferase activities were performed as described (Tora et al., 1989; Sleigh, 1986; De Wet et al., 1987) .
Two-hybrid interaction assays
Yeast two hybrid assays were performed in the yeast reporter strain PL3(a) (MATa ura3-D1 his3-D200 leu2-D1 trp1 : : 3ERE-URA3) (Pierrat et al., 1992) . Yeast transformations were done by electroporation (Becker and Guarente, 1991) . Transformants were obtained by selection for the appropriate plasmids markers and were grown exponentially for about ®ve generations in liquid medium containing uracil in the presence or absence of ligands. Yeast extracts were prepared and assayed for OMPdecase activity as described (Pierrat et al., 1992) .
